These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21165360)

  • 1. Two novel mutations of the MYBPC3 gene identified in Chinese families with hypertrophic cardiomyopathy.
    Lin J; Zheng DD; Tao Q; Yang JH; Jiang WP; Yang XJ; Song JP; Jiang TB; Li X
    Can J Cardiol; 2010 Dec; 26(10):518-22. PubMed ID: 21165360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
    Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel phenotype-genotype correlations of hypertrophic cardiomyopathy caused by mutation in α-actin and myosin-binding protein genes in three unrelated Chinese families.
    Yang QL; Bian YY; Wang B; Zuo L; Zhou MY; Shao H; Zhang YM; Liu LW
    J Cardiol; 2019 May; 73(5):438-444. PubMed ID: 30600190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
    Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
    Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland.
    Jääskeläinen P; Kuusisto J; Miettinen R; Kärkkäinen P; Kärkkäinen S; Heikkinen S; Peltola P; Pihlajamäki J; Vauhkonen I; Laakso M
    J Mol Med (Berl); 2002 Jul; 80(7):412-22. PubMed ID: 12110947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole MYBPC3 NGS sequencing as a molecular strategy to improve the efficiency of molecular diagnosis of patients with hypertrophic cardiomyopathy.
    Janin A; Chanavat V; Rollat-Farnier PA; Bardel C; Nguyen K; Chevalier P; Eicher JC; Faivre L; Piard J; Albert E; Nony S; Millat G
    Hum Mutat; 2020 Feb; 41(2):465-475. PubMed ID: 31730716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy.
    Waldmüller S; Sakthivel S; Saadi AV; Selignow C; Rakesh PG; Golubenko M; Joseph PK; Padmakumar R; Richard P; Schwartz K; Tharakan JM; Rajamanickam C; Vosberg HP
    J Mol Cell Cardiol; 2003 Jun; 35(6):623-36. PubMed ID: 12788380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy.
    Rodríguez-García MI; Monserrat L; Ortiz M; Fernández X; Cazón L; Núñez L; Barriales-Villa R; Maneiro E; Veira E; Castro-Beiras A; Hermida-Prieto M
    BMC Med Genet; 2010 Apr; 11():67. PubMed ID: 20433692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical features of dilated cardiomyopathy-like hypertrophic cardiomyopathy caused by a 13261 G > A mutation in cardiac myosin-binding protein C gene].
    Wang SX; Zou YB; Fu CY; Wang H; Wang JZ; Song XD; Chen JZ; Hui RT
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jan; 35(1):17-20. PubMed ID: 17386157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of MYBPC3 Gene Mutations in Patients with Hypertrophic Cardiomyopathy, Reporting Two Novel Mutations from North-West of Iran.
    Emrahi L; Tabrizi MT; Gharehsouran J; Ardebili SM; Estiar MA
    Clin Lab; 2016; 62(5):757-64. PubMed ID: 27348999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [P1208fs mutation in the cardiac myosin binding protein C is associated with hypertrophic cardiomyopathy in a Chinese pedigree].
    Li J; Liu LW; Na LS; Zuo L; Qi W; Liu Y; Shao H; Ma ZL; Wang LF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr; 44(4):321-6. PubMed ID: 27112610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy.
    Erdmann J; Raible J; Maki-Abadi J; Hummel M; Hammann J; Wollnik B; Frantz E; Fleck E; Hetzer R; Regitz-Zagrosek V
    J Am Coll Cardiol; 2001 Aug; 38(2):322-30. PubMed ID: 11499719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening Mutations of MYBPC3 in 114 Unrelated Patients with Hypertrophic Cardiomyopathy by Targeted Capture and Next-generation Sequencing.
    Liu X; Jiang T; Piao C; Li X; Guo J; Zheng S; Zhang X; Cai T; Du J
    Sci Rep; 2015 Jun; 5():11411. PubMed ID: 26090888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
    Chiou KR; Chu CT; Charng MJ
    J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide study on hypertrophic cardiomyopathy in Iceland: evidence of a MYBPC3 founder mutation.
    Adalsteinsdottir B; Teekakirikul P; Maron BJ; Burke MA; Gudbjartsson DF; Holm H; Stefansson K; DePalma SR; Mazaika E; McDonough B; Danielsen R; Seidman JG; Seidman CE; Gunnarsson GT
    Circulation; 2014 Sep; 130(14):1158-67. PubMed ID: 25078086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Novel MYBPC3 mutations in Chinese patients with hypertrophic cardiomyopathy].
    Ma ZF; Liu WL; Hu DY; Xie WL; Zhu TG; Sun YH; Yang SN; Li CL; Li L; Nie XY; Yang JG; Li TC; Bian H; Tong QG; Xiao J; Wang GH; Cui W; Fan RY; Li YT
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Aug; 37(8):734-8. PubMed ID: 20021930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-exome sequencing identifies rare compound heterozygous mutations in the MYBPC3 gene associated with severe familial hypertrophic cardiomyopathy.
    Zhou N; Qin S; Liu Y; Tang L; Zhao W; Pan C; Qiu Z; Wang X; Shu X
    Eur J Med Genet; 2018 Aug; 61(8):434-441. PubMed ID: 29524613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel MYBPC3 gene variant in a patient with hypertrophic cardiomyopathy.
    Brion M; Allegue C; Gil R; Blanco-Verea A; Carracedo A; Pagannone E; Evangelista A; Di Castro S; Marchitti S; Stanzione R; Volpe M; Rubattu S
    Ann Clin Lab Sci; 2010; 40(3):285-9. PubMed ID: 20689143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypes.
    Jääskeläinen P; Miettinen R; Kärkkäinen P; Toivonen L; Laakso M; Kuusisto J
    Ann Med; 2004; 36(1):23-32. PubMed ID: 15000344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.